CADM1/IGSF4A Protein, Human (HEK293, His)

Customer Review

Based on 1 Customer Validation

The CADM1/IGSF4A protein is an important mediator of cell-cell adhesion.It forms homodimers and interacts with CADM3 and NECTIN3.CADM1/IGSF4A Protein, Human (HEK293, His) is the recombinant human-derived CADM1/IGSF4A protein, expressed by HEK293 , with C-His labeled tag.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: HEK293
  • Storage:
    Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • Help & FAQs

Biological Activity

Description

The CADM1/IGSF4A protein is an important mediator of cell-cell adhesion.It forms homodimers and interacts with CADM3 and NECTIN3.CADM1/IGSF4A Protein, Human (HEK293, His) is the recombinant human-derived CADM1/IGSF4A protein, expressed by HEK293 , with C-His labeled tag.

Background

The CADM1/IGSF4A protein serves as a pivotal mediator of both homophilic and heterophilic cell-cell adhesion, operating in a Ca(2+)-independent manner. It forms homodimers and mediates homophilic adhesion, and also engages in heterophilic interactions with CADM3 and NECTIN3. The interaction between CADM1 and CRTAM promotes natural killer (NK) cell cytotoxicity, interferon-gamma (IFN-gamma) secretion by CD8+ cells, and NK cell-mediated rejection of tumors expressing CADM1. In mast cells, CADM1 plays a crucial role in attachment to and communication with nerves, being essential for mast cell development and survival in vivo. Furthermore, CADM1 is involved in the regulation of T-cell retention within the draining lymph node, required for the intestinal retention of specific T-cell subsets, and contributes to the adhesion of T-cells to gut-associated dendritic cells. Additionally, CADM1 functions as a synaptic cell adhesion molecule, playing roles in dendritic spine formation and synapse assembly. It is implicated in neuronal processes such as migration, axon growth, pathfinding, and fasciculation. Moreover, CADM1 is involved in spermatogenesis, contributing to the adhesion of spermatocytes and spermatids to Sertoli cells. In non-small-cell lung cancer (NSCLC) cells, CADM1 acts as a tumor suppressor, influencing invasive phenotypes. It forms homodimers via its Ig-like V-type domain and interacts with various proteins, including FARP1, CRTAM, EPB41L3/DAL1, MPP2, MPP3, and PALS2, facilitating diverse cellular functions and signaling pathways.

Verified Bioactivity

Measured by its binding ability in a functional ELISA. Immobilized Human CRTAM at 2 μg/mL (100 μL/well) can bind Biotinylated Human CADM1. The ED50 for this effect is 105.7 ng/mL.

MCE Validation Data

  • Purity - SDS-PAGE

    Purity - SDS-PAGE

    ≥ 95%, as determined by reducing SDS-PAGE.

  • Bioactivity - ELISA

    Bioactivity - ELISA

    Measured by its binding ability in a functional ELISA. Immobilized Human CRTAM at 2 μg/mL (100 μL/well) can bind Biotinylated Human CADM1. The ED50 for this effect is 105.7 ng/mL.

Technical Parameters

  • Species Human
  • Source HEK293
  • Tag C-His
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • CADM1 (Q45-H374)
      Accession # Q9BY67
    • His
    • C-term
  • Protein Length

    Extracellular Domain

  • Synonyms

    CADM1; Immunoglobulin Superfamily Member 4; Prev. TSLC1; Nectin-Like 2; Prev. IGSF4; TSLC-1; IGSF4A; Immunoglobulin Superfamily, Member 4; SYNCAM; TSLC1/Nectin-Like 2/IGSF4; NECL2; Truncated CADM1 Protein; Tumor Suppressor In Lung Cancer 1; CADM1 Protein;

  • AA Sequence

    QNLFTKDVTVIEGEVATISCQVNKSDDSVIQLLNPNRQTIYFRDFRPLKDSRFQLLNFSSSELKVSLTNVSISDEGRYFCQLYTDPPQESYTTITVLVPPRNLMIDIQKDTAVEGEEIEVNCTAMASKPATTIRWFKGNTELKGKSEVEEWSDMYTVTSQLMLKVHKEDDGVPVICQVEHPAVTGNLQTQRYLEVQYKPQVHIQMTYPLQGLTREGDALELTCEAIGKPQPVMVTWVRVDDEMPQHAVLSGPNLFINNLNKTDNGTYRCEASNIVGKAHSDYMLYVYDPPTTIPPPTTTTTTTTTTTTTILTIITDSRAGEEGSIRAVDH

  • Molecular Weight

    Approximately 60-95 kDa, based on SDS-PAGE under reducing conditions, due to the glycosylation.

  • Glycosylation

    Yes

  • Purity

    ≥ 95%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Lyophilized powder

Formulation

Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Reconstitution

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O.

Storage & Stability

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Shipping

Room temperature in continental US; may vary elsewhere.

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00